HomeCompareGEECF vs JNJ

GEECF vs JNJ: Dividend Comparison 2026

GEECF yields 2000000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GEECF wins by $4.879226400974806e+39M in total portfolio value
10 years
GEECF
GEECF
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full GEECF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GEECF vs JNJ

📍 GEECF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGEECFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GEECF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GEECF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GEECF
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, GEECF beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GEECF + JNJ for your $10,000?

GEECF: 50%JNJ: 50%
100% JNJ50/50100% GEECF
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GEECF
No analyst data
Altman Z
-104653.6
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GEECF buys
0
JNJ buys
0
No recent congressional trades found for GEECF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGEECFJNJ
Forward yield2000000.00%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4.879226400974806e+39M$20.0K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$827.78
Total dividends collected$4.879195005460081e+39M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GEECF vs JNJ ($10,000, DRIP)

YearGEECF PortfolioGEECF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,676$355.77+$200.00MGEECF
2$3,738,731,768,458$3,738,517,757,009.35$11,407$389.39+$3738731.76MGEECF
3$65,315,062,866,930,490$65,311,062,423,938,240.00$12,198$426.53+$65315062866.92MGEECF
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$13,056$467.62+$1066400830062625.00MGEECF
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$13,987$513.12+$16272182796453826560.00MGEECF
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$14,998$563.56+$2.3205424011366188e+23MGEECF
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$16,098$619.52+$3.0927990661046884e+27MGEECF
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$17,295$681.69+$3.8524105697352695e+31MGEECF
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$18,599$750.82+$4.484688260147987e+35MGEECF
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$20,022$827.78+$4.879226400974806e+39MGEECF

GEECF vs JNJ: Complete Analysis 2026

GEECFStock

Global Environmental Energy Corp. engages in alternative energy sources, environmental infrastructure, electrical micro-power generation and liquid fuel production. The company also develops and commercializes various technologies in the waste to energy sector, including electrical power generation and liquid fuel production. It offers Biosphere Process System, a waste to energy system that provides solutions for the conversion of waste materials, which includes municipal solid waste, agricultural or forestry surpluses or wastes, industrial or medical waste materials, and traditional fossil fuels in a process that includes automatic separation of metals and plastics, the formation of organic compost, and the heating of the organic residue left from the separation process to high temperatures in a separate chamber, which is deprived of oxygen. The company sells and operates Biosphere Systems in Asia, Europe, the Americas, and the Philippines. Global Environmental Energy Corp. was formerly known as Life Energy & Technology Holdings, Inc. and changed its name to Global Environmental Energy Corp. in Septmber, 2004. The company is based in Nassau, Bahamas. On June 5, 2007, the voluntary petition of Global Environmental Energy Corp. for reorganization under Chapter 11 was converted to Chapter 7. The Company had filed for Chapter 11 bankruptcy on May 19, 2005.

Full GEECF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GEECF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GEECF vs SCHDGEECF vs JEPIGEECF vs OGEECF vs KOGEECF vs MAINGEECF vs ABBVGEECF vs MRKGEECF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.